BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33836300)

  • 21. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiologically based pharmacokinetic modelling and in vivo [I]/K(i) accurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate.
    Zhao Y; Hu ZY
    Br J Pharmacol; 2014 Feb; 171(4):1043-53. PubMed ID: 24283665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dronedarone: a new antiarrhythmic agent.
    Zareba KM
    Drugs Today (Barc); 2006 Feb; 42(2):75-86. PubMed ID: 16541184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dronedarone: Basic Pharmacology and Clinical Use.
    Tadros R; Nattel S; Andrade JG
    Card Electrophysiol Clin; 2016 Jun; 8(2):453-65. PubMed ID: 27261834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship.
    Quaglino D; Ha HR; Duner E; Bruttomesso D; Bigler L; Follath F; Realdi G; Pettenazzo A; Baritussio A
    Am J Physiol Lung Cell Mol Physiol; 2004 Aug; 287(2):L438-47. PubMed ID: 15075249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of dronedarone in the contemporary atrial fibrillation treatment].
    Dorantowicz R; Broncel M
    Pol Merkur Lekarski; 2011 Jan; 30(175):32-40. PubMed ID: 21542242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of five anthraquinones from rhubarb with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8) and drug-drug interaction in rats.
    Ma L; Zhao L; Hu H; Qin Y; Bian Y; Jiang H; Zhou H; Yu L; Zeng S
    J Ethnopharmacol; 2014 May; 153(3):864-71. PubMed ID: 24685584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dronedarone for atrial fibrillation: a new therapeutic agent.
    Patel PD; Bhuriya R; Patel DD; Arora BL; Singh PP; Arora RR
    Vasc Health Risk Manag; 2009; 5():635-42. PubMed ID: 19688104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dronedarone: a safety comparison to amiodarone.
    Clem JR; Farver DK; Fischer JR; Johnson TJ
    Curr Drug Saf; 2010 Jul; 5(3):251-6. PubMed ID: 20210734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel antiarrhythmic drug dronedarone: comparison with amiodarone.
    Kathofer S; Thomas D; Karle CA
    Cardiovasc Drug Rev; 2005; 23(3):217-30. PubMed ID: 16252015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of dronedarone on muscarinic K+ current in guinea pig atrial cells.
    Guillemare E; Marion A; Nisato D; Gautier P
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):802-5. PubMed ID: 11117382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Garcia D; Cheng-Lai A
    Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing atrial fibrillation in the elderly: critical appraisal of dronedarone.
    Trigo P; Fischer GW
    Clin Interv Aging; 2012; 7():1-13. PubMed ID: 22291468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dronedarone.
    Patel C; Yan GX; Kowey PR
    Circulation; 2009 Aug; 120(7):636-44. PubMed ID: 19687370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.
    Belur Nagaraj A; Joseph P; Kovalenko O; Wang Q; Xu R; DiFeo A
    Gynecol Oncol; 2018 Dec; 151(3):525-532. PubMed ID: 30301560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amiodarone and dronedarone: An update.
    Vamos M; Hohnloser SH
    Trends Cardiovasc Med; 2016 Oct; 26(7):597-602. PubMed ID: 27155812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
    N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dronedarone.
    Tamargo J; López-Farré A; Caballero R; Delpón E
    Drugs Today (Barc); 2011 Feb; 47(2):109-33. PubMed ID: 21431100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.